CA2538305C - Apheresis device - Google Patents
Apheresis device Download PDFInfo
- Publication number
- CA2538305C CA2538305C CA2538305A CA2538305A CA2538305C CA 2538305 C CA2538305 C CA 2538305C CA 2538305 A CA2538305 A CA 2538305A CA 2538305 A CA2538305 A CA 2538305A CA 2538305 C CA2538305 C CA 2538305C
- Authority
- CA
- Canada
- Prior art keywords
- app
- column
- binding
- apheresis
- nucleic acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
- A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cardiology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ATA1444/2003 | 2003-09-12 | ||
| AT0144403A AT413336B (de) | 2003-09-12 | 2003-09-12 | Apherese-vorrichtung |
| PCT/AT2004/000311 WO2005025651A1 (de) | 2003-09-12 | 2004-09-13 | Apherese-vorrichtung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2538305A1 CA2538305A1 (en) | 2005-03-24 |
| CA2538305C true CA2538305C (en) | 2011-05-24 |
Family
ID=34280361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2538305A Expired - Fee Related CA2538305C (en) | 2003-09-12 | 2004-09-13 | Apheresis device |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7935252B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1663347B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4509113B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN100556472C (cg-RX-API-DMAC7.html) |
| AT (2) | AT413336B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004271651B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2538305C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1107911T1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE502004005851D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1663347T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2298789T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20080090T3 (cg-RX-API-DMAC7.html) |
| PL (1) | PL1663347T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1663347E (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005025651A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003303198A1 (en) | 2002-12-19 | 2004-07-14 | New York University | Method for treating amyloid disease |
| AT500483B1 (de) | 2004-07-13 | 2006-01-15 | Mattner Frank Dr | Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung |
| AT501621A1 (de) * | 2005-03-15 | 2006-10-15 | Mattner Frank Dr | Zusammensetzungen zur verwendung bei der vorbeugung und behandlung der alzheimer- erkrankung |
| ES2332846B1 (es) * | 2007-10-26 | 2010-07-08 | Grifols, S.A. | Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos. |
| EP2237804B1 (en) * | 2007-12-21 | 2013-04-10 | GE Healthcare Bio-Sciences AB | Method for sterilization of chemically activated solid support materials |
| US20100030196A1 (en) * | 2008-07-29 | 2010-02-04 | Medtronic, Inc. | Apheresis of a target molecule from cerebrospinal fluid |
| US20100158893A1 (en) * | 2008-12-19 | 2010-06-24 | Baxter International Inc. | Systems and methods for obtaining immunoglobulin from blood |
| CN102264411B (zh) * | 2008-12-22 | 2014-10-22 | 学校法人藤田学园 | Aβ除去材料、Aβ除去器和Aβ除去系统 |
| US20110033463A1 (en) * | 2009-08-06 | 2011-02-10 | Medtronic, Inc. | Apheresis, administration of agent, or combination thereof |
| EP2497828A1 (en) * | 2011-03-07 | 2012-09-12 | Charité - Universitätsmedizin Berlin | Use of aptamers in therapy and/or diagnosis of autoimmune diseases |
| RS53496B1 (sr) | 2011-10-04 | 2015-02-27 | Affiris Ag | POSTUPAK ZA DETEKCIJU Aβ-SPECIFIČNIH ANTITELA U BIOLOŠKOM UZORKU |
| US9717841B2 (en) | 2012-09-11 | 2017-08-01 | Gary L. McNeil | Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source |
| EP3166660B1 (en) * | 2014-07-10 | 2017-12-13 | Affiris AG | Substances and methods for the use in prevention and/or treatment in huntington's disease |
| JP6876601B2 (ja) | 2014-07-10 | 2021-05-26 | アフィリス・アクチェンゲゼルシャフトAffiris Ag | ハンチントン病の予防および/または処置における使用のための物質および方法 |
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| KR20210124308A (ko) | 2019-01-30 | 2021-10-14 | 트루바인딩 아이엔씨. | 항-gal3 항체 및 이의 용도 |
| GB201904810D0 (en) * | 2019-04-05 | 2019-05-22 | Cynapsedx Ltd | The treatment of protein aggregation diseases |
| MX2022014786A (es) | 2020-05-26 | 2023-01-16 | Truebinding Inc | Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3. |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57103649A (en) * | 1980-12-18 | 1982-06-28 | Asahi Chemical Ind | Sterilized gamma-globulin fixing column |
| US4770774A (en) * | 1985-09-19 | 1988-09-13 | Toray Industries, Inc. | Column for removing β2 -microglobulin |
| DE3880647T2 (de) * | 1987-11-20 | 1993-11-18 | Kanegafuchi Chemical Ind | Sorbentmittel für Serum-Amyloid-Proteine. |
| US5216127A (en) * | 1987-11-20 | 1993-06-01 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Adsorbent for serum amyloid protein |
| JPH01171638A (ja) * | 1987-12-25 | 1989-07-06 | Kanegafuchi Chem Ind Co Ltd | 血清アミロイドa蛋白用吸着体 |
| US5604102A (en) * | 1992-04-15 | 1997-02-18 | Athena Neurosciences, Inc. | Methods of screening for β-amyloid peptide production inhibitors |
| JPH06104122A (ja) | 1992-09-21 | 1994-04-15 | Matsushita Electric Ind Co Ltd | ロータリートランス |
| AU691297B2 (en) * | 1994-05-13 | 1998-05-14 | Miltenyi Biotec Gmbh | Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood |
| DE19515554C2 (de) * | 1995-04-27 | 1999-06-17 | Braun Melsungen Ag | Verwendung eines Mittels und Vorrichtung zur simultanen extrakorporalen Elimination von Tumor-Nekrose-Faktor alpha und bakteriellen Lipopolysacchariden aus Vollblut oder/und Blutplasma |
| US5868936A (en) * | 1996-06-20 | 1999-02-09 | Baxter International Inc. | Affinity membrane system and method of using same |
| US6787523B1 (en) * | 1997-12-02 | 2004-09-07 | Neuralab Limited | Prevention and treatment of amyloidogenic disease |
| EA006606B1 (ru) | 2000-02-24 | 2006-02-24 | Вашингтон Юниверсити | Гуманизированное антитело и его фрагмент, взаимодействующие с бета-амилоидным пептидом, и способы их применения |
| TWI238251B (en) * | 2000-07-13 | 2005-08-21 | Anawrhta Biotech Co Ltd | In-vitro adsorbing device using immunity |
| US20050227941A1 (en) * | 2001-12-17 | 2005-10-13 | Karen Duff | Sequestration of ass in the periphery in the absence of immunomodulating agent as a therapeutic approach for the treatment or prevention of beta-amyloid related diseases |
| AU2003303198A1 (en) * | 2002-12-19 | 2004-07-14 | New York University | Method for treating amyloid disease |
| AT413945B (de) * | 2003-01-14 | 2006-07-15 | Mattner Frank Dr | Impfstoff für die alzheimer-krankheit |
| AT413946B (de) * | 2004-07-13 | 2006-07-15 | Mattner Frank Dr | Impfstoff gegen die alzheimer-krankheit |
| AT500835B1 (de) * | 2004-09-13 | 2007-12-15 | Affiris Forschungs & Entwicklungs Gmbh | Cholinestertransport-protein-mimotop als atherosklerose-medikament |
-
2003
- 2003-09-12 AT AT0144403A patent/AT413336B/de not_active IP Right Cessation
-
2004
- 2004-09-13 PL PL04761033T patent/PL1663347T3/pl unknown
- 2004-09-13 PT PT04761033T patent/PT1663347E/pt unknown
- 2004-09-13 DK DK04761033T patent/DK1663347T3/da active
- 2004-09-13 US US10/571,469 patent/US7935252B2/en not_active Expired - Fee Related
- 2004-09-13 AU AU2004271651A patent/AU2004271651B2/en not_active Ceased
- 2004-09-13 WO PCT/AT2004/000311 patent/WO2005025651A1/de not_active Ceased
- 2004-09-13 JP JP2006525566A patent/JP4509113B2/ja not_active Expired - Fee Related
- 2004-09-13 CA CA2538305A patent/CA2538305C/en not_active Expired - Fee Related
- 2004-09-13 AT AT04761033T patent/ATE382383T1/de active
- 2004-09-13 CN CNB2004800303263A patent/CN100556472C/zh not_active Expired - Fee Related
- 2004-09-13 EP EP04761033A patent/EP1663347B1/de not_active Expired - Lifetime
- 2004-09-13 ES ES04761033T patent/ES2298789T3/es not_active Expired - Lifetime
- 2004-09-13 DE DE502004005851T patent/DE502004005851D1/de not_active Expired - Lifetime
- 2004-09-13 HR HR20080090T patent/HRP20080090T3/xx unknown
-
2008
- 2008-03-21 CY CY20081100330T patent/CY1107911T1/el unknown
-
2011
- 2011-03-17 US US13/049,994 patent/US20110166327A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20080090T3 (hr) | 2008-03-31 |
| ATA14442003A (de) | 2005-07-15 |
| US20110166327A1 (en) | 2011-07-07 |
| DE502004005851D1 (de) | 2008-02-14 |
| EP1663347A1 (de) | 2006-06-07 |
| JP4509113B2 (ja) | 2010-07-21 |
| AT413336B (de) | 2006-02-15 |
| US20070026029A1 (en) | 2007-02-01 |
| ES2298789T3 (es) | 2008-05-16 |
| EP1663347B1 (de) | 2008-01-02 |
| HK1096320A1 (zh) | 2007-06-01 |
| CA2538305A1 (en) | 2005-03-24 |
| CY1107911T1 (el) | 2013-09-04 |
| CN1867365A (zh) | 2006-11-22 |
| DK1663347T3 (da) | 2008-05-19 |
| JP2007504863A (ja) | 2007-03-08 |
| US7935252B2 (en) | 2011-05-03 |
| PT1663347E (pt) | 2008-03-28 |
| CN100556472C (zh) | 2009-11-04 |
| AU2004271651B2 (en) | 2009-08-06 |
| WO2005025651A1 (de) | 2005-03-24 |
| PL1663347T3 (pl) | 2008-06-30 |
| AU2004271651A1 (en) | 2005-03-24 |
| ATE382383T1 (de) | 2008-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20110166327A1 (en) | Apheresis device | |
| Sanchez et al. | The selective therapeutic apheresis procedures | |
| US11529445B2 (en) | Methods and apparatus for kidney dialysis and extracorporeal detoxification | |
| US20060030027A1 (en) | Capture and removal of biomolecules from body fluids using partial molecular imprints | |
| EP2058335B1 (en) | Biocompatible three dimensional matrix for the immobilization of biological substances | |
| JP2004516896A (ja) | 細胞外体液からの特異的生体高分子物質の体外捕獲 | |
| NZ330102A (en) | Immunoadsorbents for extracorporal apheresis in patients suffering from immune disorders | |
| WO2020176683A1 (en) | Whole blood treatment device and methods of removing target agents from whole blood | |
| US20180093032A1 (en) | Targeted apheresis using binding agents or ligands immobilized on membranes | |
| Spina et al. | Chemically modified poly (2‐hydroxyethyl methacrylate) cryogel for the adsorption of heparin | |
| EP4003451B1 (en) | Device for extracorporeal lowering of asymmetric dimethylarginine and monomethyl arginine levels in human blood | |
| Drexler et al. | Albumin dialysis molecular adsorbents recirculating system: impact of dialysate albumin concentration on detoxification efficacy | |
| KR101139103B1 (ko) | 아페레시스 장치 | |
| JPS62192172A (ja) | 吸着体 | |
| HK1096320B (zh) | 分离性输血-设备 | |
| WO2005025650A1 (de) | Apherese-vorrichtung | |
| JP7255899B2 (ja) | 組織または流体から分子を選択的に除去するためのデバイス | |
| WO2007111969A2 (en) | C-reactive protein apheresis | |
| RU2098140C1 (ru) | Способ проведения экстракорпоральной иммуносорбции | |
| JPH01265972A (ja) | 体液中の有害成分の除去方法 | |
| EP4717352A1 (en) | A whole-blood compatible matrix for extracorporeal blood treatment | |
| JPH01158970A (ja) | 直接血液潅流用免疫グロブリン吸着材および吸着装置 | |
| JP2000217909A (ja) | 吸着材 | |
| Müller-Schulte et al. | Removal of β2-microglobulin using grafted affinity adsorbents as therapeutic approach for the treatment of hemodialysis patients | |
| JPH0611335B2 (ja) | 吸着体および除去装置 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20170913 |